Canada markets open in 2 hours 41 minutes

Cybin Inc. (CYBN)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.4300+0.0008 (+0.19%)
At close: 04:00PM EDT
0.4300 0.00 (0.00%)
Pre-Market: 05:58AM EDT

Cybin Inc.

100 King Street West
Suite 5600
Toronto, ON M5X 1C9
Canada

https://www.cybin.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees50

Key Executives

NameTitlePayExercisedYear Born
Mr. Eric So L.L.B.Co-Founder, President & Executive Chairman459.43kN/A1976
Mr. Douglas L. DrysdaleChief Executive Officer614.17kN/A1970
Mr. Paul GlavineCo-Founder, Chief Growth Officer & Director459.43kN/A1989
Mr. Greg CaversChief Financial Officer242.38kN/A1971
Mr. Aaron BartloneChief Operating Officer379.57kN/AN/A
Mr. John KanakisCo-Founder704.87kN/A1980
Dr. Alex L. Nivorozhkin Ph.D.Chief Scientific OfficerN/AN/A1960
Ms. Lori ChallengerChief Compliance, Ethics & Administrative OfficerN/AN/AN/A
Mr. Gabriel FahelChief Legal Officer & Corporate SecretaryN/AN/A1976
Sara Brittany SomersetChief Communications OfficersN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cybin Inc., a clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog, which is in Phase 1/2a clinical trial to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine, which is in Phase 1 clinical trial for treating generalized anxiety disorders; and CYB005, a phenethylamine derivative, which in preclinical stage to treat neuroinflammation. It has also developed EMBARK, a psychological support model that integrates clinical approaches to promote supportive healing with psychedelic medicine. The company is headquartered in Toronto, Canada.

Corporate Governance

Cybin Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.